Insiders-FDA granted based on Ethyl-EPA under 505b FDA act on NCE
Ethyl-EPA not Just EPA , Amarin will get exclusive marketing rights for Vascepa over the next five years. An important factor in deciding whether Vascepa NCE status, Now it compares to the drug Lovaza in $1.7Billion Market.
Maybe you're dumb enough to deserve being "boiler" scammed - if the FDA believed your arguments Vascepa would have been DENIED NCE months ago! EPA + DHA made Lovaza effective. Vascepa is EPA alone, which delivers dramatically different (better) results. Thus, the new FDA committee to award uses of known chemicals the NCE (5yr) status. The FDA wants to encourage exploration and use of known entities in new ways. Thus the committee and thus the inevitable NCE approval.